KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Net Margin (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Net Margin data on record, last reported at 1.72% in Q4 2025.

  • For Q4 2025, Net Margin fell 112.0% year-over-year to 1.72%; the TTM value through Dec 2025 reached 0.22%, down 5077.0%, while the annual FY2025 figure was 0.22%, 5077.0% down from the prior year.
  • Net Margin reached 1.72% in Q4 2025 per EW's latest filing, up from 0.13% in the prior quarter.
  • Across five years, Net Margin topped out at 199.89% in Q3 2024 and bottomed at 0.51% in Q1 2025.
  • Average Net Margin over 5 years is 26.76%, with a median of 14.72% recorded in 2023.
  • Peak YoY movement for Net Margin: surged 19596bps in 2024, then plummeted -20002bps in 2025.
  • A 5-year view of Net Margin shows it stood at 25.22% in 2021, then surged by 268bps to 92.67% in 2022, then plummeted by -97bps to 2.89% in 2023, then fell by -2bps to 2.84% in 2024, then crashed by -39bps to 1.72% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 1.72% in Q4 2025, 0.13% in Q3 2025, and 0.29% in Q2 2025.